- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: 60.8%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | -0.90 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2024 (4) | 0.51 | 0 | 0.30 | 0 | 0.00 | 0 | 58.82 | 0 | 0.00 | 0 | 58.82 | 0 |
| 2023 (3) | -0.15 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | -0.10 | 75.61 | -150.0 | -0.22 | 63.33 | 0 | -0.10 | 88.89 | -150.0 |
| 25Q4 (7) | -0.41 | -57.69 | -1125.0 | -0.60 | -57.89 | -328.57 | -0.90 | -80.0 | -276.47 |
| 25Q3 (6) | -0.26 | 40.91 | -174.29 | -0.38 | -323.53 | -3700.0 | -0.50 | -108.33 | -206.38 |
| 25Q2 (5) | -0.44 | -320.0 | -210.0 | 0.17 | 0 | -22.73 | -0.24 | -220.0 | -300.0 |
| 25Q1 (4) | 0.20 | 400.0 | 0.0 | 0.00 | 100.0 | 0.0 | 0.20 | -60.78 | 0.0 |
| 24Q4 (3) | 0.04 | -88.57 | 0.0 | -0.14 | -1300.0 | 0.0 | 0.51 | 8.51 | 0.0 |
| 24Q3 (2) | 0.35 | -12.5 | 0.0 | -0.01 | -104.55 | 0.0 | 0.47 | 291.67 | 0.0 |
| 24Q2 (1) | 0.40 | 0.0 | 0.0 | 0.22 | 0.0 | 0.0 | 0.12 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/6 | 2.52 | -8.72 | -18.05 | 15.42 | -30.9 | 7.81 | N/A | - | ||
| 2026/5 | 2.76 | 9.42 | -8.16 | 12.9 | -32.96 | 7.91 | N/A | - | ||
| 2026/4 | 2.53 | -3.62 | -28.36 | 10.13 | -37.56 | 7.31 | N/A | - | ||
| 2026/3 | 2.62 | 21.44 | -52.5 | 7.61 | -40.11 | 7.61 | 1.03 | 係子公司亞洲客戶出貨減少所致。 | ||
| 2026/2 | 2.16 | -23.68 | -40.47 | 4.99 | -30.59 | 7.55 | 1.04 | - | ||
| 2026/1 | 2.83 | 10.15 | -20.52 | 2.83 | -20.52 | 7.55 | 1.04 | - | ||
| 2025/12 | 2.57 | 19.13 | -47.33 | 36.3 | -46.71 | 6.92 | 1.17 | - | ||
| 2025/11 | 2.15 | -1.84 | -53.93 | 33.73 | -46.66 | 6.64 | 1.22 | 子公司主要客戶出貨減少所致 | ||
| 2025/10 | 2.2 | -4.11 | -65.44 | 31.57 | -46.08 | 6.65 | 1.21 | 子公司主要客戶出貨減少所致 | ||
| 2025/9 | 2.29 | 5.65 | -62.67 | 29.38 | -43.73 | 7.06 | 1.07 | 子公司主要客戶出貨減少所致 | ||
| 2025/8 | 2.17 | -16.76 | -70.92 | 27.09 | -41.21 | 7.85 | 0.96 | 子公司主要客戶出貨減少所致 | ||
| 2025/7 | 2.6 | -15.44 | -67.66 | 24.92 | -35.47 | 8.69 | 0.87 | 子公司主要客戶出貨減少所致 | ||
| 2025/6 | 3.08 | 2.28 | -62.05 | 22.32 | -26.99 | 9.62 | 0.86 | 子公司主要客戶出貨減少所致 | ||
| 2025/5 | 3.01 | -14.64 | -57.63 | 19.24 | -14.33 | 12.06 | 0.69 | 子公司2024年度主要客戶出貨減少所致 | ||
| 2025/4 | 3.53 | -36.1 | -38.82 | 16.23 | 5.71 | 12.67 | 0.65 | - | ||
| 2025/3 | 5.52 | 52.22 | 67.58 | 12.7 | 32.48 | 12.7 | 0.84 | 子公司配合客戶出貨時程 | ||
| 2025/2 | 3.63 | 1.89 | 20.94 | 7.18 | 14.11 | 12.06 | 0.89 | - | ||
| 2025/1 | 3.56 | -27.01 | 7.91 | 3.56 | 7.91 | 13.11 | 0.82 | - | ||
| 2024/12 | 4.87 | 4.19 | 62.06 | 68.12 | 60.09 | 15.91 | 0.83 | 子公司新市場出貨增加所致 | ||
| 2024/11 | 4.68 | -26.35 | 42.81 | 63.24 | 59.94 | 17.17 | 0.77 | 子公司新市場出貨增加所致 | ||
| 2024/10 | 6.35 | 3.55 | 69.09 | 58.57 | 61.49 | 19.94 | 0.66 | 子公司新市場出貨增加所致 | ||
| 2024/9 | 6.13 | -17.69 | 61.36 | 52.21 | 60.61 | 21.64 | 0.81 | 子公司新市場出貨增加所致 | ||
| 2024/8 | 7.45 | -7.43 | 112.11 | 46.08 | 60.51 | 23.62 | 0.74 | 子公司新市場出貨增加所致 | ||
| 2024/7 | 8.05 | -0.76 | 138.55 | 38.62 | 53.31 | 23.27 | 0.75 | 子公司新市場出貨增加所致 | ||
| 2024/6 | 8.11 | 14.21 | 100.27 | 30.57 | 40.12 | 20.98 | 0.99 | 子公司新市場出貨增加所致 | ||
| 2024/5 | 7.1 | 23.26 | 125.66 | 22.46 | 26.41 | 16.16 | 1.28 | 子公司新市場出貨增加所致 | ||
| 2024/4 | 5.76 | 75.03 | 73.1 | 15.35 | 5.03 | 12.06 | 1.72 | 子公司新市場出貨增加所致 | ||
| 2024/3 | 3.29 | 9.85 | -15.03 | 9.59 | -15.04 | 9.59 | N/A | - | ||
| 2024/2 | 3.0 | -9.07 | -16.4 | 6.3 | -15.05 | 9.3 | N/A | - | ||
| 2024/1 | 3.3 | 9.61 | -13.79 | 3.3 | -13.79 | 9.58 | N/A | - | ||
| 2023/12 | 3.01 | -8.18 | -43.06 | 42.55 | -28.3 | 10.04 | N/A | - | ||
| 2023/11 | 3.28 | -12.8 | -29.19 | 39.54 | -26.86 | 10.83 | N/A | - | ||
| 2023/10 | 3.76 | -1.17 | -17.35 | 36.27 | -26.64 | 11.07 | N/A | - | ||
| 2023/9 | 3.8 | 8.18 | -40.13 | 32.51 | -27.58 | 10.69 | N/A | - | ||
| 2023/8 | 3.51 | 4.09 | -31.92 | 28.71 | -25.51 | 10.94 | N/A | - | ||
| 2023/7 | 3.38 | -16.68 | -27.76 | 25.19 | -24.52 | 10.58 | N/A | - | ||
| 2023/6 | 4.05 | 28.69 | -20.9 | 21.82 | -24.0 | 10.53 | N/A | - | ||
| 2023/5 | 3.15 | -5.44 | -37.54 | 17.76 | -24.67 | 10.35 | N/A | - | ||
| 2023/4 | 3.33 | -14.08 | -30.62 | 14.62 | -21.17 | 10.79 | N/A | - | ||
| 2023/3 | 3.88 | 8.08 | -23.64 | 11.29 | -17.87 | 11.29 | N/A | - | ||
| 2023/2 | 3.59 | -6.25 | -3.37 | 7.41 | -14.49 | 12.69 | N/A | - | ||
| 2023/1 | 3.83 | -27.6 | -22.81 | 3.83 | -22.81 | 13.74 | N/A | - | ||
| 2022/12 | 5.28 | 14.19 | 1.1 | 59.35 | 12.58 | 14.46 | N/A | - | ||
| 2022/11 | 4.63 | 1.78 | -0.43 | 54.07 | 13.84 | 15.52 | N/A | - | ||
| 2022/10 | 4.55 | -28.41 | 10.64 | 49.44 | 15.39 | 16.06 | N/A | - | ||
| 2022/9 | 6.35 | 23.02 | 29.19 | 44.89 | 15.89 | 16.19 | N/A | - | ||
| 2022/8 | 5.16 | 10.45 | 25.13 | 38.54 | 13.96 | 14.96 | N/A | - | ||
| 2022/7 | 4.67 | -8.76 | 6.01 | 33.38 | 12.41 | 14.84 | N/A | - | ||
| 2022/6 | 5.12 | 1.61 | 9.1 | 28.71 | 13.52 | 14.96 | N/A | - | ||
| 2022/5 | 5.04 | 5.03 | 24.23 | 23.58 | 14.53 | 14.92 | N/A | - | ||
| 2022/4 | 4.8 | -5.44 | 10.43 | 18.54 | 12.15 | 13.59 | N/A | - | ||
| 2022/3 | 5.08 | 36.77 | 16.96 | 13.74 | 12.77 | 13.74 | N/A | - | ||
| 2022/2 | 3.71 | -25.11 | 6.89 | 8.67 | 10.44 | 13.89 | N/A | - | ||
| 2022/1 | 4.96 | -5.15 | 13.26 | 4.96 | 13.26 | 14.83 | N/A | - | ||
| 2021/12 | 5.23 | 12.45 | -0.69 | 52.72 | -16.52 | 13.98 | N/A | - | ||
| 2021/11 | 4.65 | 13.1 | -4.93 | 47.49 | -17.96 | 13.67 | N/A | - | ||
| 2021/10 | 4.11 | -16.41 | -28.87 | 42.84 | -19.16 | 13.15 | N/A | - | ||
| 2021/9 | 4.92 | 19.15 | -24.14 | 38.74 | -17.97 | 13.45 | N/A | - | ||
| 2021/8 | 4.13 | -6.42 | -34.28 | 33.82 | -16.99 | 0.0 | N/A | - | ||
| 2021/7 | 4.41 | -6.1 | -28.26 | 29.69 | -13.84 | 0.0 | N/A | - |